Top Glove Corporation (7113) Fair Value & Analysis
Healthcare · MY · Market cap 6.6B MYR
Fair value as of: Jun 24, 2026
From 26 valuation models · updated 7 days ago
Fair value updated Jun 24, 2026 — revised from 0.3600 MYR to 0.3500 MYR (−2.8%) since Jun 23, 2026. Share price −14.9% over the past month.
Price vs Fair Value (12 months)
12‑month range 0.5490 MYR – 0.8612 MYR · fair‑value band 0.2600 MYR – 0.4400 MYR · the 0.6900 MYR price screens above the 0.3500 MYR fair value. As of Jun 24, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Top Glove Corporation (7113) currently trades at 0.6900 MYR, while our model-based Fair Value estimate is 0.3500 MYR — implying the stock looks roughly 49.3% overvalued today. We read business quality at 60/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, Top Glove Corporation generated revenue of 3.6B MYR at a net margin of 3.9%. Revenue grew 13.7% year over year. It earns a return on equity of 2.9%. Net debt stands at 551M MYR. Fundamentals as of Jun 24, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
Top Glove Corporation Bhd., an investment holding company, engages in the manufacture, trade, and sale of gloves in Malaysia, Thailand, the People's Republic of China, and internationally. It offers nitrile, latex, surgical, rubber, examination, medical, and vinyl gloves; concentrate and synthetic latex, formers, chemicals and chemical compounds, rubber dental dams, exercise bands, condoms, and rubber related products; packaging materials, boxes, and cartons; and disposable and medical face masks, engineering parts and rubber glove machinery, functional fillers, healthcare products, and home care and personal care products. The company also provides property investment and consultancy services, and electrical engineering works; clinical and specialist medical services; analytical, medical related consultancy, emergency medical, advisory, accommodation, management and trading, and value added services; financial and treasury services; management services in plantation sector; …
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Top Glove Corporation reported revenue of 3.5B MYR in FY2025 versus 16.4B MYR in FY2021, a compound −32.0%/yr. Reported net income was 128M MYR in FY2025, compounding −64.1%/yr from FY2021.
Is 7113 fairly valued? → Check now
Similar stocks
6 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Intuitive Surgical, Inc ISRG | $422.06 | $165.35 | -61% |
| EssilorLuxottica Société anonyme ESLOF | $192.00 | $126.51 | -34% |
| HOYA Corporation HOCPY | $168.16 | $96.16 | -43% |
| Medline Inc MDLN | $36.54 | $30.66 | -16% |
| Becton, Dickinson and Company BDX | $147.79 | $124.26 | -16% |
| Alcon Inc ALC | $65.18 | $44.21 | -32% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Top Glove Corporation (7113) undervalued?
What is the fair value of 7113?
What is the quality score of 7113?
What is the revenue of Top Glove Corporation (7113)?
What is the net profit margin of 7113?
Does Top Glove Corporation pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.